Financial Results for the Quarter and Half year ended 30 September 2026

Shilpa Medicare Limited Corporate & Admin Office: “Shilpa House”, # 12-6-214/A-1, Hyderabad Road, Raichur – 584 135, Karnataka, India Tel: +91-8532-238704, Fax: +91-8532-238876 Email: info@vbshilpa.com, Web: www.vbshilpa.com CIN: L85110KA1987PLC008739 Date: 05 November 2026 Corporate Relationship Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, 5" Floor, Phiroze Jeejeebhoy Towers, Plot No.C/1, G Block Dalal Street, Fort, Bandra Kurla Complex, Bandra (E) Mumbai-400 001 Mumbai-400 051 Scrip Code: BSE - 530549/ Stock Symbol: NSE – SHILPAMED Sub: Outcome of the Board Meeting of the Company held on 05 November 2026 Dear Sir/ Ma’am, Pursuant to Regulations 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e. on Thursday, November 5, 2026, inter alia, approved the Unaudited Consolidated and Standalone Financial Results of the Company for the second quarter and half year ended September 30, 2026. The said Unaudited Financial Results along with the Limited Review Report of the Statutory Auditors thereon are enclosed herewith. The Board meeting commenced at 11:00 a.m. (IST) and concluded at 12:45 p.m. (IST). Weblink:- https://vbshilpa.com/stock-exchange-intimations.php The above is for your information and dissemination. Thanking you For and on behalf of Shilpa Medicare Limited Ritu Tiwary Company Secretary & Compliance Officer